-+ 0.00%
-+ 0.00%
-+ 0.00%

Stifel Initiates Coverage On Korsana Biosciences with Buy Rating, Announces Price Target of $43

Benzinga·09/14/2026 18:01:59
Listen to the news
Stifel analyst Paul Matteis initiates coverage on Korsana Biosciences (NASDAQ:KRSA) with a Buy rating and announces Price Target of $43.